359 related articles for article (PubMed ID: 25241368)
1. Second-dose methotrexate in ectopic pregnancies: the role of beta human chorionic gonadotropin.
Cohen A; Bibi G; Almog B; Tsafrir Z; Levin I
Fertil Steril; 2014 Dec; 102(6):1646-9. PubMed ID: 25241368
[TBL] [Abstract][Full Text] [Related]
2. Do serum beta-human chorionic gonadotropin levels on day 4 following methotrexate treatment of patients with ectopic pregnancy predict successful single-dose therapy?
Gabbur N; Sherer DM; Hellmann M; Abdelmalek E; Phillip P; Abulafia O
Am J Perinatol; 2006 Apr; 23(3):193-6. PubMed ID: 16586235
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate treatment in progressive tubal ectopic pregnancies and hCG-related clinicosurgical implications.
Dogan A; Gulhan I; Uyar I; Ekin A; Gezer C; Bilgin M; Taner CE; Ertas IE
Kaohsiung J Med Sci; 2016 Jun; 32(6):317-22. PubMed ID: 27377845
[TBL] [Abstract][Full Text] [Related]
4. Role of initial and day 4 human chorionic gonadotropin levels in predicting the outcome of single-dose methotrexate treatment in women with tubal ectopic pregnancy.
Ustunyurt E; Duran M; Coskun E; Ustunyurt ÖB; Simşek H
Arch Gynecol Obstet; 2013 Nov; 288(5):1149-52. PubMed ID: 23666603
[TBL] [Abstract][Full Text] [Related]
5. Single-dose methotrexate for the treatment of unruptured ectopic pregnancy.
Erdem M; Erdem A; Arslan M; Oç A; Biberoğlu K; Gürsoy R
Arch Gynecol Obstet; 2004 Dec; 270(4):201-4. PubMed ID: 12955534
[TBL] [Abstract][Full Text] [Related]
6. Are early human chorionic gonadotropin levels after methotrexate therapy a predictor of response in ectopic pregnancy?
Nguyen Q; Kapitz M; Downes K; Silva C
Am J Obstet Gynecol; 2010 Jun; 202(6):630.e1-5. PubMed ID: 20510964
[TBL] [Abstract][Full Text] [Related]
7. Increment in beta-hCG in the 48-h period prior to treatment: a new variable predictive of therapeutic success in the treatment of ectopic pregnancy with methotrexate.
da Costa Soares R; Elito J; Camano L
Arch Gynecol Obstet; 2008 Oct; 278(4):319-24. PubMed ID: 18274766
[TBL] [Abstract][Full Text] [Related]
8. Routine β-Human Chorionic Gonadotropin Monitoring for Single-Dose Methotrexate Treatment in Ectopic Pregnancy.
Dai Y; Zhang G; Zhu L; Lang J; Liu Z
J Minim Invasive Gynecol; 2017; 24(7):1195-1199. PubMed ID: 28800968
[TBL] [Abstract][Full Text] [Related]
9. Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy.
Nowak-Markwitz E; Michalak M; Olejnik M; Spaczynski M
Fertil Steril; 2009 Oct; 92(4):1203-1207. PubMed ID: 18851850
[TBL] [Abstract][Full Text] [Related]
10. Single-dose methotrexate treatment for ectopic pregnancy and pregnancy of unknown location and progesterone as a predictor of success.
Wu J; Ludlow JP; De Vries B; Black K; Beale P
Aust N Z J Obstet Gynaecol; 2014 Oct; 54(5):469-74. PubMed ID: 25287564
[TBL] [Abstract][Full Text] [Related]
11. An alternative monitoring protocol for single-dose methotrexate therapy in ectopic pregnancy.
Thurman AR; Cornelius M; Korte JE; Fylstra DL
Am J Obstet Gynecol; 2010 Feb; 202(2):139.e1-6. PubMed ID: 19962125
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of systemic methotrexate in the treatment of unruptured tubal pregnancy.
Soliman KB; Saleh NM; Omran AA
Saudi Med J; 2006 Jul; 27(7):1005-10. PubMed ID: 16830020
[TBL] [Abstract][Full Text] [Related]
13. Early prediction for the requirement of second or third dose methotrexate in women with ectopic pregnancy, treated with single-dose regimen.
Yıldırım A; Cırık DA; Altay M; Gelisen O
Arch Gynecol Obstet; 2015 Jun; 291(6):1327-32. PubMed ID: 25516179
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate success rates in progressing ectopic pregnancies: a reappraisal.
Cohen A; Zakar L; Gil Y; Amer-Alshiek J; Bibi G; Almog B; Levin I
Am J Obstet Gynecol; 2014 Aug; 211(2):128.e1-5. PubMed ID: 24657132
[TBL] [Abstract][Full Text] [Related]
15. Predicting success of methotrexate treatment by pretreatment HCG level and 24-hour HCG increment.
Levin G; Saleh NA; Haj-Yahya R; Matan LS; Avi B
Int J Gynaecol Obstet; 2018 Apr; 141(1):70-73. PubMed ID: 29154410
[TBL] [Abstract][Full Text] [Related]
16. The role of HCG increment in the 48h prior to methotrexate treatment as a predictor for treatment success.
Cohen A; Almog B; Cohen Y; Bibi G; Rimon E; Levin I
Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():103-107. PubMed ID: 28214759
[TBL] [Abstract][Full Text] [Related]
17. Cut-off value of initial serum β-hCG level predicting a successful MTX therapy in tubal ectopic pregnancy: a retrospective cohort study.
Helmy S; Bader Y; Pablik E; Tiringer D; Pils S; Laml T; Kölbl H; Koch M
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():175-80. PubMed ID: 24956362
[TBL] [Abstract][Full Text] [Related]
18. ß-hCG and prediction of therapeutic success in ectopic pregnancies treated with methotrexate, results from a prospective observational study.
Orozco EM; Sánchez-Durán MA; Bello-Muñoz JC; Sagalá J; Carreras E; Roura LC
J Matern Fetal Neonatal Med; 2015 Apr; 28(6):695-9. PubMed ID: 24871360
[TBL] [Abstract][Full Text] [Related]
19. The role of day 0 and day 4 β-human chorionic gonadotropin values and initial ultrasound findings in predicting the success of methotrexate treatment in ectopic pregnancy.
Tasgoz FN; Temur M; Dundar B; Kartal E; Ustunyurt E
Ginekol Pol; 2020; 91(7):389-393. PubMed ID: 32779159
[TBL] [Abstract][Full Text] [Related]
20. Day 1 change in maternal serum β-HCG levels as an early predictor of successful medical therapy in ectopic pregnancies.
Ahmed MR; Sayed Ahmed WA; Mohamed TY
J Matern Fetal Neonatal Med; 2020 Jul; 33(14):2403-2407. PubMed ID: 30608010
[No Abstract] [Full Text] [Related]
[Next] [New Search]
